We are live on !
Find out more
NF Trinity Capital Portfolio holdings
AUM
$626M
Turnover
24%
1-Year Est. Return
3.16%
This Fund
S&P 500
This Quarter Est. Return
+9.73%
1 Year Est. Return
+3.16%
3 Year Est. Return
+49.61%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$700M
AUM Growth
-$4.98M
(-0.71%)
Cap. Flow
-$12M
Cap. Flow % of AUM
Cap. Flow %
-1.71%
Top 10 Holdings %
Top 10 Hldgs %
65.48%
Holding
53
New
8
Increased
9
Reduced
3
Closed
5
Avg Time Held
Equity + Options
1.1
years
Top 10 Avg Time Held
Equity + Options
1.3
years
Top 20 Avg Time Held
Equity + Options
1.3
years
Avg Time Held Equity only
1.1
years
Top 10 Avg Time Held Equity only
1.3
years
Top 20 Avg Time Held Equity only
1.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$9.5M |
| 2 |
Citigroup
C
|
+$8.53M |
| 3 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
+$7.03M |
| 4 |
JD.com
JD
|
+$6.01M |
| 5 |
Amazon
AMZN
|
+$5.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$24.6M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$9.7M |
| 3 |
Bank of America
BAC
|
+$8.01M |
| 4 |
Acadia Pharmaceuticals
ACAD
|
+$5.72M |
| 5 |
Neurocrine Biosciences
NBIX
|
+$4.84M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 26.19% |
| 2 | Consumer Discretionary | 20.6% |
| 3 | Technology | 13.67% |
| 4 | Healthcare | 12.96% |
| 5 | Miscellaneous | 12.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Alibaba
BABA
$268B
| $122M | 17.37% |
704,382
| – | – |
2015 Q4
7 quarters
|
|
2
Apple
AAPL
$5.04T
| $52.6M | 7.51% |
1,365,588
| – | – |
2015 Q4
7 quarters
|
|
|
3
Bank of America
BAC
$345B
| $52.4M | 7.48% |
2,066,982
-330,000
| -14% | -$8.01M |
2015 Q4
7 quarters
|
|
4
Alphabet (Google) Class A
GOOGL
$3.5T
| $50M | 7.14% |
1,028,000
| – | – |
2015 Q4
7 quarters
|
|
5
Meta Platforms (Facebook)
META
$1.55T
| $48.1M | 6.86% |
281,300
+24,000
| +9% | +$4.01M |
2015 Q4
7 quarters
|
|
6
Walt Disney
DIS
$203B
| $38.8M | 5.53% |
393,230
| – | – |
2015 Q4
7 quarters
|
|
7
iShares Biotechnology ETF
IBB
$11.2B
| $28.8M | 4.11% |
259,050
| – | – |
2015 Q4
7 quarters
|
|
|
8
Baidu
BIDU
$27B
| $26.7M | 3.81% |
107,757
-112,900
| -51% | -$24.6M |
2015 Q4
7 quarters
|
|
|
AGN
9
DELISTED
Allergan plc
AGN
| $22.4M | 3.2% |
109,448
+13,800
| +14% | +$3.21M |
2015 Q4
7 quarters
|
|
10
State Street Energy Select Sector SPDR ETF
XLE
$41.2B
| $17.2M | 2.46% |
502,560
| – | – |
2015 Q4
7 quarters
|
|
|
11
Citigroup
C
$195B
| $16.5M | 2.36% |
226,930
+125,000
| +123% | +$8.53M |
2015 Q4
7 quarters
|
|
|
12
JD.com
JD
$38.8B
| $16.3M | 2.33% |
426,835
+140,500
| +49% | +$6.01M |
2016 Q1
6 quarters
|
|
13
Universal Display
OLED
$3.9B
| $15.7M | 2.24% |
121,994
+14,105
| +13% | +$1.71M |
2016 Q3
4 quarters
|
|
|
14
State Street Health Care Select Sector SPDR ETF
XLV
$48.9B
| $13.8M | 1.97% |
169,100
-121,000
| -42% | -$9.7M |
2015 Q4
7 quarters
|
|
15
Bristol-Myers Squibb
BMY
$129B
| $11.9M | 1.69% |
186,000
| – | – |
2015 Q4
7 quarters
|
|
|
CELG
16
DELISTED
Celgene Corp
CELG
| $10.3M | 1.48% |
70,917
| – | – |
2015 Q4
7 quarters
|
|
|
17
State Street SPDR S&P Biotech ETF
XBI
$10.2B
| $10.3M | 1.47% |
+119,000
| New | +$9.5M |
2017 Q3
0 quarters
|
|
18
Mastercard
MA
$573B
| $9.8M | 1.4% |
69,400
| – | – |
2015 Q4
7 quarters
|
|
19
Lockheed Martin
LMT
$134B
| $9.31M | 1.33% |
30,000
| – | – |
2016 Q1
6 quarters
|
|
|
XLNX
20
DELISTED
Xilinx Inc
XLNX
| $8.57M | 1.22% |
121,000
+45,000
| +59% | +$2.94M |
2017 Q2
1 quarter
|
|
21
BioMarin Pharmaceuticals
BMRN
$10.9B
| $8.37M | 1.19% |
89,900
| – | – |
2017 Q1
2 quarters
|
|
22
T-Mobile US
TMUS
$169B
| $8.18M | 1.17% |
132,600
+79,600
| +150% | +$4.99M |
2017 Q2
1 quarter
|
|
23
Liberty Global Class A
LBTYA
$3.26B
| $8.05M | 1.15% |
237,371
| – | – |
2015 Q4
7 quarters
|
|
|
GBT
24
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $7.76M | 1.11% |
+250,000
| New | +$7.03M |
2017 Q3
0 quarters
|
|
25
Biogen
BIIB
$36.4B
| $7.52M | 1.07% |
24,000
| – | – |
2015 Q4
7 quarters
|
|
Similar funds
SHCM
IAS
NF Trinity Capital's Q3 2017 Portfolio in Review
As of Q3 2017, NF Trinity Capital held 53 positions worth $700M, down 0.71% from $705M the previous quarter. Its ten largest holdings account for 65% of the portfolio.
NF Trinity Capital's Q3 2017 filing shows 8 new, 9 increased, 3 reduced and 5 closed positions. Its largest new stake was State Street SPDR S&P Biotech ETF: 119,000 shares worth $10.3M. The largest sale was Baidu, an estimated $24.6M.
By sector, the portfolio is most concentrated in Communication Services at 26% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Technology.
- NF Trinity Capital's largest Q3 2017 buy was State Street SPDR S&P Biotech ETF: 119,000 shares worth $10.3M.
- NF Trinity Capital added most to Citigroup in Q3 2017, an estimated $8.53M increase.
- NF Trinity Capital's biggest Q3 2017 reduction was Baidu, cutting an estimated $24.6M.
- NF Trinity Capital fully exited Acadia Pharmaceuticals in Q3 2017, selling an estimated $5.72M.
- NF Trinity Capital's ten largest holdings make up 65% of its $700M portfolio in Q3 2017.
- NF Trinity Capital opened 8 new positions and closed 5 in Q3 2017.
- NF Trinity Capital's portfolio value fell 0.71% quarter-over-quarter to $700M.
Based on NF Trinity Capital's 13F filing for Q3 2017, filed 7 Nov 2017.